KAYLA GATTO: Open Payments
NPI 1124690219 · GREENFIELD TOWNSHIP, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 34 payments from 11 companies in 2025. Trend: 2023 $353 · 2024 $265 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $138 |
| Janssen Pharmaceuticals, Inc | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 4 | $56 |
| Indivior Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 2 | $28 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
Products named: VRAYLAR, INVEGA SUSTENNA, FANAPT, REXULTI, COBENFY, SUBLOCADE, AUSTEDO XR, UZEDY.
Industry payments across PA — which companies pay providers there.
